Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients.
Block MS, Dietz AB, Gustafson MP, Kalli KR, Erskine CL, Youssef B, Vijay GV, Allred JB, Pavelko KD, Strausbauch MA, Lin Y, Grudem ME, Jatoi A, Klampe CM, Wahner-Hendrickson AE, Weroha SJ, Glaser GE, Kumar A, Langstraat CL, Solseth ML, Deeds MC, Knutson KL, Cannon MJ.
Block MS, et al. Among authors: deeds mc.
Nat Commun. 2020 Oct 14;11(1):5173. doi: 10.1038/s41467-020-18962-z.
Nat Commun. 2020.
PMID: 33057068
Free PMC article.
Clinical Trial.